Interesting that there are a number of "Not Held" &"SELL" contributors here - my guess is that, after JBH's fairly good run-up over recent months from $60. that they were expecting a pull-back with the results (given economic stresses across retail, and lack of interest rate reduction) and were/are still hoping to get JBH cheaper.
So 8% sp rise today (as I write) was a surprise to me.
Generally it is Day#2 after a results report when we can expect a more considered response from the market - so let's see what tomorrow brings.
However, one way to look at today's results is:
- consistent result but for trimmed (-15%) profit (as one would expect in current economic circumstances)
- still growing at CPI (ie July sales)
- throwing off more cash than needed for business
- investing in growth (and in higher margin business)
- recognising shareholder interests (distributing free cashflow and franking credits)
- dominant business in its field, with ability to leverage that.
So, I expect that more investors will see less risk in JBH, and see it as a more investible and more reliable growth+yield stock. That could support a higher P/E margin than otherwise.
- Forums
- ASX - By Stock
- Ann: Results Presentation - 2024 Full Year Results
Interesting that there are a number of "Not Held" &"SELL"...
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add JBH (ASX) to my watchlist
|
|||||
Last
$75.41 |
Change
2.430(3.33%) |
Mkt cap ! $8.224B |
Open | High | Low | Value | Volume |
$74.77 | $75.49 | $73.88 | $38.17M | 508.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 136 | $75.41 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$75.42 | 95 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6 | 75.390 |
6 | 110 | 75.380 |
4 | 23 | 75.370 |
1 | 13 | 75.360 |
2 | 38 | 75.350 |
Price($) | Vol. | No. |
---|---|---|
75.400 | 13 | 2 |
75.410 | 777 | 8 |
75.420 | 7 | 1 |
75.430 | 38 | 2 |
75.440 | 79 | 5 |
Last trade - 14.10pm 13/08/2024 (20 minute delay) ? |
Featured News
JBH (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online